A story in the BBC reports on the expected shift in human embryonic stem cell research policy under the incoming Obama administration. Many scientists are hopeful that he will lift the restrictive 2001 ban on certain cell lines, while others hope to see an infusion of cash and increased policy to support true bench-to-bedside research. "The impact of eight years under the previous administration for stem cell research has really been devastating," says Tom Okarma, head of stem cell company Geron.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.